Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Immunity to rotaviruses.

R Edelman, J Flores, A Z Kapikian

    Current Topics in Microbiology and Immunology
    |January 1, 1989
    PubMed
    Summary
    This summary is machine-generated.

    Developing potent rotavirus (RV) vaccines and better potency tests could reduce country-specific efficacy trials. Continued trials are needed due to differing RV pathogenesis and epidemiology globally, despite advances in RV vaccinology.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    More on RotaShield and intussusception: the role of age at the time of vaccination.

    The Journal of infectious diseases·2005
    Same author

    Taste and odor profiles (off-flavors) in the drinking waters of the Barcelona area (1996-2000).

    Water science and technology : a journal of the International Association on Water Pollution Research·2004
    Same author

    Calcifying epithelial odontogenic tumor in a dog.

    Journal of veterinary dentistry·2004
    Same author

    Spinal cord compression due to tumoral idiopatic calcinosis.

    Spinal cord·2003
    Same author

    Immunogenicity of a recombinant human immunodeficiency virus (HIV)-canarypox vaccine in HIV-seronegative Ugandan volunteers: results of the HIV Network for Prevention Trials 007 Vaccine Study.

    The Journal of infectious diseases·2003
    Same author

    Bioavailability of ranitidine in healthy Mexican volunteers: effect of food.

    Proceedings of the Western Pharmacology Society·2002
    Same journal

    Resolution Biology in Soft Tissue Joint Disease.

    Current topics in microbiology and immunology·2026
    Same journal

    A 25+ Year Journey on Yeast-Regulated Cell Death Research.

    Current topics in microbiology and immunology·2026
    Same journal

    Adoptive T-Cell Immunotherapy.

    Current topics in microbiology and immunology·2026
    Same journal

    Resolution Pharmacology Targeting the Melanocortin System.

    Current topics in microbiology and immunology·2026
    Same journal

    Resolution of Skeletal Muscle Inflammation: Role of Specialized Pro-resolving Lipid Mediators in the Recovery from Exercise, Injury, and Disease.

    Current topics in microbiology and immunology·2026
    Same journal

    Epstein-Barr Virus: From the Detection of Sequence Polymorphisms to the Recognition of Viral Strains.

    Current topics in microbiology and immunology·2026
    See all related articles

    Area of Science:

    • Immunology
    • Vaccinology
    • Infectious Diseases

    Background:

    • Rotavirus (RV) remains a significant global health concern, necessitating effective vaccination strategies.
    • Current RV vaccine deployment requires country-specific efficacy pretesting due to variations in disease epidemiology and pathogenesis.
    • Advances in RV vaccinology have outpaced the understanding of RV immunopathogenesis and epidemiology.

    Purpose of the Study:

    • To highlight the need for potent, multivalent, and serotype-specific RV vaccines.
    • To emphasize the importance of improved assays for measuring vaccine potency.
    • To underscore the ongoing necessity for global vaccine trials.

    Main Methods:

    • The study is a review and synthesis of current knowledge on RV vaccines and epidemiology.

    Related Experiment Videos

  • It analyzes the complexities of RV vaccinology in relation to immunopathogenesis.
  • It discusses the implications of differing RV serotype characteristics across diverse geographical regions.

    • Main Results:

    • A potent, multivalent, serotype-specific RV vaccine could potentially eliminate the need for extensive pretesting.
    • Improved potency testing methods are crucial for reliable vaccine assessment.
    • Significant variations in RV pathogenesis and epidemiology necessitate continued vaccine trials in various countries.

    Conclusions:

    • Further development of RV vaccines and potency assays is critical for global health.
    • Understanding RV immunopathogenesis and epidemiology is essential for optimizing vaccine strategies.
    • Despite complexities, RV vaccinology continues to progress, offering hope for disease control.